BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15134361)

  • 21. Comparison of the effects of antimicrobial agents from three different classes on metabolism of isoflavonoids by colonic microflora using Etest strips.
    Sutherland JB; Bridges BM; Heinze TM; Adams MR; Delio PJ; Hotchkiss C; Rafii F
    Curr Microbiol; 2012 Jan; 64(1):60-5. PubMed ID: 22006071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and identification of equol-producing bacterial strains from cultures of pig faeces.
    Yu ZT; Yao W; Zhu WY
    FEMS Microbiol Lett; 2008 May; 282(1):73-80. PubMed ID: 18328079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ileal and faecal digestibility of daidzein and genistein and plasma bioavailability of these isoflavones and their bioactive metabolites in the ovariectomised rat.
    Poulsen RC; Loots du T; Moughan PJ; Kruger MC
    Mol Nutr Food Res; 2009 May; 53 Suppl 1():S27-35. PubMed ID: 19156712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism of dietary soy isoflavones to equol by human intestinal microflora--implications for health.
    Yuan JP; Wang JH; Liu X
    Mol Nutr Food Res; 2007 Jul; 51(7):765-81. PubMed ID: 17579894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concentrations of isoflavones in macaques consuming standard laboratory monkey diet.
    Stroud FC; Appt SE; Wilson ME; Franke AA; Adams MR; Kaplan JR
    J Am Assoc Lab Anim Sci; 2006 Jul; 45(4):20-3. PubMed ID: 16884174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. R(-)-O-desmethylangolensin is the main enantiomeric form of daidzein metabolite produced by human in vitro and in vivo.
    Gardana C; Canzi E; Simonetti P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Mar; 953-954():30-7. PubMed ID: 24561352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism of daidzein by Nocardia species NRRL 5646 and Mortierella isabellina ATCC 38063.
    Maatooq GT; Rosazza JP
    Phytochemistry; 2005 May; 66(9):1007-11. PubMed ID: 15896369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dihydrodaidzein-producing Clostridium-like intestinal bacterium, strain TM-40, affects in vitro metabolism of daidzein by fecal microbiota of human male equol producer and non-producers.
    Tamura M; Hori S; Nakagawa H
    Biosci Microflora; 2011; 30(3):65-71. PubMed ID: 25045313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enantioselective synthesis of S-equol from dihydrodaidzein by a newly isolated anaerobic human intestinal bacterium.
    Wang XL; Hur HG; Lee JH; Kim KT; Kim SI
    Appl Environ Microbiol; 2005 Jan; 71(1):214-9. PubMed ID: 15640190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation of human intestinal bacteria metabolizing the natural isoflavone glycosides daidzin and genistin.
    Hur HG; Lay JO; Beger RD; Freeman JP; Rafii F
    Arch Microbiol; 2000 Dec; 174(6):422-8. PubMed ID: 11195098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lactulose promotes equol production and changes the microbial community during in vitro fermentation of daidzein by fecal inocula of sows.
    Zheng W; Hou Y; Su Y; Yao W
    Anaerobe; 2014 Feb; 25():47-52. PubMed ID: 24315807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is equol production beneficial to health?
    Magee PJ
    Proc Nutr Soc; 2011 Feb; 70(1):10-8. PubMed ID: 21092366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation and characterisation of an equol-producing mixed microbial culture from a human faecal sample and its activity under gastrointestinal conditions.
    Decroos K; Vanhemmens S; Cattoir S; Boon N; Verstraete W
    Arch Microbiol; 2005 Jan; 183(1):45-55. PubMed ID: 15578160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative Inhibitions of 5-Lipoxygenase and Myeloperoxidase and Free-Radical Scavenging Activities of Daidzein, Dihydrodaidzein, and Equol.
    Tsen SY; Tan XY; Tan YM; Yan BY; Loke WM
    J Med Food; 2016 Jun; 19(6):543-8. PubMed ID: 27027338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbial equol production attenuates colonic methanogenesis and sulphidogenesis in vitro.
    Bolca S; Verstraete W
    Anaerobe; 2010 Jun; 16(3):247-52. PubMed ID: 20298796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of an equol-producing bacterium isolated from human faeces on isoflavone and lignan metabolism in mice.
    Tamura M; Hori S; Nakagawa H; Yamauchi S; Sugahara T
    J Sci Food Agric; 2016 Jul; 96(9):3126-32. PubMed ID: 26455424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on the antioxidant properties of some phytoestrogens.
    Kładna A; Berczyński P; Kruk I; Piechowska T; Aboul-Enein HY
    Luminescence; 2016 Sep; 31(6):1201-6. PubMed ID: 26799817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in fecal excretion of cholesterol and bacterial degradation products in high- and low-responding rhesus monkeys: implications in colon cancer.
    Bhattacharyya AK; Eggen DA; Correa P; Strong JP
    Nutr Cancer; 1989; 12(1):69-73. PubMed ID: 2496397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation and identification of an isoflavone reducing bacterium from feces from a pregnant horse.
    Jinglong X; Xiaobin L; Fang Z; Chenchen W; Kailun Y
    PLoS One; 2019; 14(11):e0223503. PubMed ID: 31738752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasorelaxant and antioxidant activity of the isoflavone metabolite equol in carotid and cerebral arteries.
    Jackman KA; Woodman OL; Chrissobolis S; Sobey CG
    Brain Res; 2007 Apr; 1141():99-107. PubMed ID: 17274967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.